Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTSGNASDAQ:RDNTNASDAQ:SHCNASDAQ:VRDN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTSGBrightSpring Health Services$18.50+0.2%$20.14$9.85▼$24.82$3.24B2.21.27 million shs233,915 shsRDNTRadNet$51.20+0.9%$57.96$45.82▼$93.65$3.79B1.85614,214 shs350,050 shsSHCSotera Health$11.77+0.6%$12.89$10.71▼$17.08$3.34B1.921.15 million shs290,535 shsVRDNViridian Therapeutics$14.49+2.3%$16.87$11.40▼$27.20$1.18B1.051.15 million shs124,144 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTSGBrightSpring Health Services-0.91%+0.71%-4.89%+4.94%+87.32%RDNTRadNet+0.04%+0.02%-15.69%-30.27%+4.99%SHCSotera Health-2.01%-4.49%-13.21%-13.47%+1.39%VRDNViridian Therapeutics-4.32%-8.23%-11.11%-28.59%-18.48%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTSGBrightSpring Health Services2.548 of 5 stars2.53.00.00.02.70.01.9RDNTRadNet3.865 of 5 stars3.71.00.04.62.02.50.0SHCSotera Health2.8534 of 5 stars3.31.00.00.03.03.31.3VRDNViridian Therapeutics1.3256 of 5 stars3.41.00.00.02.90.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTSGBrightSpring Health Services 2.90Moderate Buy$21.6717.12% UpsideRDNTRadNet 3.40Buy$73.2543.07% UpsideSHCSotera Health 2.60Moderate Buy$16.0036.00% UpsideVRDNViridian Therapeutics 2.75Moderate Buy$35.70146.41% UpsideCurrent Analyst Ratings BreakdownLatest VRDN, RDNT, SHC, and BTSG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/24/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$74.00 ➝ $60.003/5/2025RDNTRadNetRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$85.00 ➝ $65.002/28/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$17.00 ➝ $16.002/18/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$18.00 ➝ $17.001/29/2025BTSGBrightSpring Health ServicesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $30.001/22/2025RDNTRadNetTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$94.00 ➝ $88.001/22/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$85.00 ➝ $74.001/15/2025RDNTRadNetJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$100.00 ➝ $80.001/7/2025VRDNViridian TherapeuticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$38.00 ➝ $38.00(Data available from 3/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTSGBrightSpring Health Services$11.27B0.29$0.36 per share50.87$3.42 per share5.41RDNTRadNet$1.83B2.07$2.72 per share18.81$11.79 per share4.34SHCSotera Health$1.10B3.03$1.15 per share10.27$1.57 per share7.49VRDNViridian Therapeutics$302K3,909.12N/AN/A$4.48 per share3.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTSGBrightSpring Health Services-$154.60M-$0.12N/A22.56N/A-0.38%4.16%0.99%5/1/2025 (Estimated)RDNTRadNet$3.04M$0.03N/A96.60N/A-0.25%4.29%1.45%5/6/2025 (Estimated)SHCSotera Health$51.38M$0.1547.0616.81N/A6.31%42.27%6.02%5/1/2025 (Estimated)VRDNViridian Therapeutics-$237.73M-$3.77N/AN/AN/A-85,127.16%-70.12%-41.49%5/6/2025 (Estimated)Latest VRDN, RDNT, SHC, and BTSG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 million2/27/2025Q4 2024VRDNViridian Therapeutics-$1.05-$0.81+$0.24-$0.81$0.05 million$0.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTSGBrightSpring Health ServicesN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/AVRDNViridian TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTSGBrightSpring Health Services1.631.350.97RDNTRadNet0.892.162.16SHCSotera Health4.912.882.61VRDNViridian Therapeutics0.0418.5518.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTSGBrightSpring Health ServicesN/ARDNTRadNet77.90%SHCSotera Health91.03%VRDNViridian TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipBTSGBrightSpring Health ServicesN/ARDNTRadNet5.12%SHCSotera Health55.12%VRDNViridian Therapeutics0.65%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTSGBrightSpring Health Services35,000174.97 millionN/AOptionableRDNTRadNet8,97074.04 million70.24 millionOptionableSHCSotera Health3,000283.47 million127.12 millionOptionableVRDNViridian Therapeutics5081.49 million78.70 millionOptionableVRDN, RDNT, SHC, and BTSG HeadlinesRecent News About These CompaniesRaymond James Financial Inc. Makes New $6.02 Million Investment in Viridian Therapeutics, Inc. (NASDAQ:VRDN)March 25 at 3:19 AM | marketbeat.comAnalysts Set Viridian Therapeutics, Inc. (NASDAQ:VRDN) PT at $35.70March 23, 2025 | americanbankingnews.comCommit To Buy Viridian Therapeutics At $12.50, Earn 13.2% Annualized Using OptionsMarch 22, 2025 | nasdaq.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by Yiheng Capital Management L.P.March 22, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)March 22, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from AnalystsMarch 20, 2025 | marketbeat.comViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by Bank of New York Mellon CorpMarch 19, 2025 | marketbeat.com410,440 Shares in Viridian Therapeutics, Inc. (NASDAQ:VRDN) Acquired by Victory Capital Management Inc.March 15, 2025 | marketbeat.comViridian Therapeutics appoints new director, sees board resignationMarch 12, 2025 | investing.comCandriam S.C.A. Has $14.02 Million Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)March 7, 2025 | marketbeat.comResearch Analysts Issue Forecasts for VRDN Q1 EarningsMarch 6, 2025 | marketbeat.comFisher Asset Management LLC Acquires 23,103 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN)March 5, 2025 | marketbeat.comQ2 Earnings Forecast for VRDN Issued By B. RileyMarch 4, 2025 | marketbeat.comViridian Therapeutics Faces Uncertainty Amid Regulatory Approval ChallengesMarch 4, 2025 | tipranks.comWhat is Leerink Partnrs' Forecast for VRDN FY2029 Earnings?March 3, 2025 | marketbeat.comQ1 EPS Estimates for Viridian Therapeutics Raised by WedbushMarch 3, 2025 | marketbeat.comViridian Therapeutics: Positive Data In TED, Strong Cash Position, 1.5-Year WindowMarch 2, 2025 | seekingalpha.comWedbush Reduces Earnings Estimates for Viridian TherapeuticsMarch 1, 2025 | marketbeat.comViridian Therapeutics (NASDAQ:VRDN) Posts Earnings Results, Beats Expectations By $0.24 EPSFebruary 28, 2025 | marketbeat.comViridian Therapeutics Reports Strong Progress and FinancialsFebruary 28, 2025 | tipranks.comViridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Lags Revenue EstimatesFebruary 27, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVRDN, RDNT, SHC, and BTSG Company DescriptionsBrightSpring Health Services NASDAQ:BTSG$18.52 +0.05 (+0.28%) As of 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.RadNet NASDAQ:RDNT$51.17 +0.45 (+0.89%) As of 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Sotera Health NASDAQ:SHC$11.76 +0.08 (+0.64%) As of 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.Viridian Therapeutics NASDAQ:VRDN$14.49 +0.33 (+2.33%) As of 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intuitive Machines Gains After Earnings Beat, NASA Missions Ahead Maybe It’s Time to Buy Some GameStop Stock Intel's Strategy to Win the Next AI Frontier Is Alphabet Too Cheap to Ignore After Its Recent Correction? Qualcomm Stock Is Coiling for a Breakout Tesla Stock: Has the Mother of All Comebacks Begun? Fortinet: A Top Cybersecurity Stock With Growth Catalysts Energy Transfer: Powering Data With Dividends and Diversification Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.